中国同辐:中核秦同首批碳-14同位素产品成功上市

格隆汇资讯
19 May

格隆汇5月19日丨中国同辐(01763.HK)发布公告,中国同辐旗下中核秦山同位素有限公司(“中核秦同”)于2025年5月16日成功启运首批碳-14同位素产品,标志着我国商用堆产碳-14同位素实现从自主研发、自主生产到市场化供应的全产业链贯通。此次上市的碳-14同位素产品由中核秦同自主设计、建设的国内首条百居里级碳[14C]酸钡工业化生产线生产,设计年产能达200居里╱年,采用高效干法工艺提取,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10